e-Drug3D

2190

ZIDEBACTAM


INN
ZIDEBACTAM

cas 1436861-97-0
CLASS

ANTIINFECTIVES
A BETA-LACTAMASE INHIBITOR
TREATMENT OF ADULT PATIENTS WITH COMPLICATED URINARY TRACT INFECTIONS (CUTI)

ROUTE (list)

INTRAVENOUS

ATC code

PK parameters

VD 15.5 LITER
Cl 6.2 LITER / HOUR
PPB 4.7 PERCENT
t1/2 1.7 HOUR

Solubility

FREELY SOLUBLE IN WATER


Target

TARGET BETA-LACTAMASE

DrugCentral

-

Download SDF file 1,6-Diazabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-6-(sulfooxy)-, 2-[2-[(3R)-3-piperidinylcarbonyl]hydrazide], (1R,2S,5R)-

Formula:
C13H21N5O7S

Calculated chemical properties:

MW 391.42
NB_atoms 26
XLogP -1.86
PSA 160.443
NB_HD 4
NB_HA 12
fsp3 0.77
Lipinski(0=no;1=yes) 0

FDA
NDA 220787 (label) INN (CEFEPIME HYDROCHLORIDE ; ZIDEBACTAM) ZAYNICH (WOCKHARDT BIO AG) APPROVAL= AP YEAR= 2026

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL